Azathioprine Can Be Safely Continued Perioperatively During Appendectomy in IBD Patients
Yes, azathioprine should be continued perioperatively in patients with inflammatory bowel disease undergoing appendectomy. The evidence clearly demonstrates that thiopurines (azathioprine and mercaptopurine) do not increase postoperative complications and stopping them immediately before surgery provides no benefit.
Key Evidence Supporting Continuation
The 2023 ECCO guidelines explicitly state that immunomodulators can be continued during the perioperative period 1. Multiple systematic reviews have found no increase in postoperative complications with thiopurine use 1. This is further supported by research showing that azathioprine/6-mercaptopurine use before colectomy is not associated with increased early or late complications 2, and that these agents do not significantly increase infectious complication risk 3.
The Pharmacologic Rationale
The pharmacokinetics of azathioprine make perioperative discontinuation futile 1. Here's why:
- Azathioprine takes up to 3 months to reach therapeutic levels
- It requires a further 3 months to fully wash out of the system
- The elimination half-life is only 1-2 hours
Therefore, stopping azathioprine immediately before surgery will have no measurable impact on complication risk. The drug's immunosuppressive effects are related to its long-term metabolic activity, not its immediate presence.
Practical Management for Appendectomy
Continue azathioprine through the perioperative period without interruption. For appendectomy specifically:
- Preoperatively: Continue the patient's usual azathioprine dose up until surgery
- Perioperatively: If the patient is nil by mouth, azathioprine can be held temporarily (given its short half-life)
- Postoperatively: Resume azathioprine as soon as oral intake is reestablished 1
Critical Distinction: Steroids Are the Real Problem
The major perioperative risk comes from corticosteroids, not azathioprine 1, 4. Steroids increase postoperative infectious complications (OR 1.68,95% CI 1.24-2.28) 1, particularly at doses ≥20 mg prednisolone daily 4. If your patient is on both azathioprine and steroids, focus your attention on minimizing or tapering the steroids preoperatively when possible, not the azathioprine.
Important Caveats
Monitor for TPMT/NUDT15 deficiency 5. Patients with these genetic deficiencies are at increased risk of severe myelotoxicity. If your patient has known deficiency:
- Homozygous deficiency: Consider alternative therapy
- Heterozygous deficiency: Reduce dosing
Watch for cytopenias 5. While continuation is safe, maintain vigilance for bone marrow suppression, particularly in the postoperative period when stress and inflammation are present.
Contrast with Other IBD Medications
For context, biologics (anti-TNF, vedolizumab, ustekinumab) can also be continued perioperatively without increased risk 1. However, steroids should be minimized or stopped when possible 4, and tofacitinib requires caution with prolonged VTE prophylaxis 1.
Bottom line: Continue azathioprine through appendectomy. Focus your perioperative optimization efforts on steroid reduction, nutritional status, and standard surgical risk factors—not on stopping azathioprine.